The Utility of (Fractional Flow Reserve)FFR Before and After Successful Percutaneous Coronary Intervention
1 other identifier
observational
700
0 countries
N/A
Brief Summary
The purpose of this study is to analyze the data of patients who underwent FFR evaluation at CAVHS to evaluate the impact of PCI on coronary hemodynamics in patients with baseline ischemic FFR, the potential etiologies of suboptimal FFR post PCI, determine potential measures taken to correct persistently suboptimal FFR and PCI, and determine rate of clinical events, utility of routine Post PCI FFR strategy compared to pre PCI FFR strategy only, and evaluate the "Warranty Period" of non-ischemic FFR in different sub groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2009
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2015
CompletedFirst Submitted
Initial submission to the registry
August 12, 2019
CompletedFirst Posted
Study publicly available on registry
January 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
ExpectedFebruary 17, 2025
February 1, 2025
6.1 years
August 12, 2019
February 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Impact of PCI
• Evaluate the impact of PCI on coronary hemodynamics in patients with baseline ischemic FFR compared to final FFR
Immediately post procedure
Secondary Outcomes (5)
Potential etiologies of suboptimal FFR
Immediately post procedure
Determine potential corrective measures
Immediately post procedure
Determine rate of clinical events
Immediately post procedure
Compare post PCI FFR strategy to pre PCI FFR only
Immediately post procedure
Evaluate "Warranty Period"
Through end of study, approximately 5 years
Eligibility Criteria
Patients that have undergone FFR at CAVHS between 3/2009 and 3/2015 will be reviewed. Comparison of baseline, angiographic, procedural and outcome variables for patients with FFR\>0.9 and \<0.9 will be done using unpaired Student's t-test for continuous variables and the chi square test( χ2 ) for categorical or dichotomous variables. Unadjusted annual event rates for those with and without FFR\>0.9 will be calculated by first estimating overall event rates for these groups through calculation of Kaplan-Meier(K-M) curves, then dividing the event rate by the mean follow-up time for each of the groups. Additionally, median pre and post FFR, (%) diameter stenosis will be calculated for patients with and without clinical outcomes.Univariate predictors of post PCI, FFR,and MACE will recorded.
You may qualify if:
- Patients that have undergone FFR at CAVHS between 3/2009 and 3/2015.
You may not qualify if:
- No FFR
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (8)
Lotfi A, Jeremias A, Fearon WF, Feldman MD, Mehran R, Messenger JC, Grines CL, Dean LS, Kern MJ, Klein LW; Society of Cardiovascular Angiography and Interventions. Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography: a consensus statement of the Society of Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2014 Mar 1;83(4):509-18. doi: 10.1002/ccd.25222. Epub 2013 Nov 13. No abstract available.
PMID: 24227282BACKGROUNDHanekamp CE, Koolen JJ, Pijls NH, Michels HR, Bonnier HJ. Comparison of quantitative coronary angiography, intravascular ultrasound, and coronary pressure measurement to assess optimum stent deployment. Circulation. 1999 Mar 2;99(8):1015-21. doi: 10.1161/01.cir.99.8.1015.
PMID: 10051294BACKGROUNDPijls NH, Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, Escaned J, Tsurumi Y, Akasaka T, Samady H, De Bruyne B; Fractional Flow Reserve (FFR) Post-Stent Registry Investigators. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002 Jun 25;105(25):2950-4. doi: 10.1161/01.cir.0000020547.92091.76.
PMID: 12081986BACKGROUNDFearon WF, Luna J, Samady H, Powers ER, Feldman T, Dib N, Tuzcu EM, Cleman MW, Chou TM, Cohen DJ, Ragosta M, Takagi A, Jeremias A, Fitzgerald PJ, Yeung AC, Kern MJ, Yock PG. Fractional flow reserve compared with intravascular ultrasound guidance for optimizing stent deployment. Circulation. 2001 Oct 16;104(16):1917-22. doi: 10.1161/hc4101.097539.
PMID: 11602494BACKGROUNDBech GJ, Pijls NH, De Bruyne B, Peels KH, Michels HR, Bonnier HJ, Koolen JJ. Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation. 1999 Feb 23;99(7):883-8. doi: 10.1161/01.cir.99.7.883.
PMID: 10027810BACKGROUNDKlauss V, Erdin P, Rieber J, Leibig M, Stempfle HU, Konig A, Baylacher M, Theisen K, Haufe MC, Sroczynski G, Schiele T, Siebert U. Fractional flow reserve for the prediction of cardiac events after coronary stent implantation: results of a multivariate analysis. Heart. 2005 Feb;91(2):203-6. doi: 10.1136/hrt.2003.027797.
PMID: 15657233BACKGROUNDLeesar MA, Satran A, Yalamanchili V, Helmy T, Abdul-Waheed M, Wongpraparut N. The impact of fractional flow reserve measurement on clinical outcomes after transradial coronary stenting. EuroIntervention. 2011 Dec;7(8):917-23. doi: 10.4244/EIJV7I8A145.
PMID: 22157476BACKGROUNDDupouy P, Gilard M, Morelle JF, Furber A, Aptecar E, Cazaux P, Slama M, Feldman LJ, Wittenberg O, Pernes JM, Huret B, Commeau P, Boschat J, Teiger E, Lafont A, Steg PG, Dubois Rande JL. Usefulness and clinical impact of a fractional flow reserve and angiographic targeted strategy for coronary artery stenting: FROST III, a multicenter prospective registry. EuroIntervention. 2005 May;1(1):85-92.
PMID: 19758882BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barry Uretsky, MD
CAVHS
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2019
First Posted
January 13, 2020
Study Start
March 1, 2009
Primary Completion
March 31, 2015
Study Completion (Estimated)
December 31, 2028
Last Updated
February 17, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share